Adverum Biotechnologies, Inc. (ADVM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 11:08AM EDT. Market open.
| Previous close | 10.19 |
| Open | 10.20 |
| Bid | 9.66 x 200 |
| Ask | 11.14 x 100 |
| Day's range | 9.55 - 10.22 |
| 52-week range | 7.10 - 29.70 |
| Volume | |
| Avg. volume | 288,120 |
| Market cap | 203.811M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
Here is how Adverum Biotechnologies (ADVM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.
- Zacks
Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
Adverum Biotechnologies (ADVM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- Zacks
Are Medical Stocks Lagging Adverum Biotechnologies (ADVM) This Year?
Here is how Adverum Biotechnologies (ADVM) and Cigna (CI) have performed compared to their sector so far this year.
© 2024 Yahoo. All rights reserved.